← Browse by Condition
Medical Condition

aortic valve diseases

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for aortic valve diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic valve diseases Clinical Trials

How many clinical trials are currently recruiting for aortic valve diseases?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for aortic valve diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic valve diseases?
aortic valve diseases research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic valve diseases clinical trial?
Eligibility criteria for aortic valve diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Danderyd Hospital 1 trial
Joon Bum Kim 1 trial
Xijing Hospital 1 trial

Recruiting Clinical Trials

NCT07476703
Recruiting
Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
Enrollment
1,400 pts
Location
Sweden
Sponsor
Danderyd Hospital
View Trial →
NCT04258488 Phase 4
Recruiting
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
Enrollment
1,300 pts
Location
South Korea
Sponsor
Joon Bum Kim
View Trial →
NCT06830499
Recruiting
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
Enrollment
450 pts
Location
China
Sponsor
Xijing Hospital
View Trial →

Related Conditions

coronary artery disease (1) arterial stiffness blood pressure (1) mitral valve stenosis and or insufficiency (1) heart failure (1) pulmonary disease chronic obstructive copd (1) steatohepatitis (1) inflammation biomarkers (1) lipid profile (1) oral microbiota (1) masld metabolic dysfunction associated steatotic liver disease (1) metabolic associated dysfunction steatohepatitis mash (1) thromboembolism (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology